LISATA THERAPEUTICS, INC. — Director's Dealing 2015

Apr 14, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NeoStem, Inc. (NBS)
CIK: 0000320017
Period of Report: 2015-04-13

Reporting Person: VACZY CATHERINE M (General Counsel)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-04-13	Common Stock, $0.001 par value	A	3971	—	Acquired	71234	Direct

Footnotes

F1: On April 13, 2015, the Reporting Person was granted an award of 3,971 shares of Common Stock (the "Shares"), subject to all of the terms and conditions of the Issuer's Amended and Restated 2009 Equity Compensation Plan. The Shares were fully vested upon grant. The award was approved by the Issuer's Compensation Committee in lieu of certain cash reimbursements to which she was entitled under the terms of her employment agreement.